Mario Mikula

Masaryk Memorial Cancer Institute — Czech Republic

Medicine · Health Sciences

27h-index4.0kcitations78works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(9), Liver physiology and pathology(8), Melanoma and MAPK Pathways(7), PI3K/AKT/mTOR signaling in cancer(6), Epigenetics and DNA Methylation(5)

Publications77 total

2372eP Treatment patterns and clinical outcomes associated with androgen deprivation therapy in advanced prostate cancer: A nationwide retrospective study in the Czech Republic
Annals of Oncology·2025Open Access
Expression of the cholesterol transporter SR-B1 in melanoma cells facilitates inflammatory signaling leading to reduced cholesterol synthesis
Neoplasia·2025· 1 citedOpen Access
Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation
British Journal of Cancer·2024· 6 citedOpen Access
Dynamic regulation of tumour progression by phenotype‐switching drivers
Clinical and Translational Medicine·2022· 1 citedOpen Access
Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up‐regulation and increased apoptosis resistance upon vemurafenib treatment
Cancer Medicine·2021· 16 citedOpen Access
Plasma Membrane Lipids: An Important Binding Site for All Lipoprotein Classes
Membranes·2021· 7 citedOpen Access
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway
Oncogene·2020· 62 citedOpen Access
Insights into Differentiation of Melanocytes from Human Stem Cells and Their Relevance for Melanoma Treatment
Cancers·2020· 18 citedOpen Access
Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis
JCI Insight·2019· 25 citedOpen Access
Metabolism of cholesterol and progesterone is differentially regulated in primary trophoblastic subtypes and might be disturbed in recurrent miscarriages
Journal of Lipid Research·2019· 43 citedOpen Access
Genome amplification and cellular senescence are hallmarks of human placenta development
Yearbook of pediatric endocrinology·2019· 1 cited
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Cell Death and Disease·2019Open Access
Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma
International Journal of Molecular Sciences·2019· 14 citedOpen Access
Genome amplification and cellular senescence are hallmarks of human placenta development
PLoS Genetics·2018· 99 citedOpen Access
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pigmentation pathway
2018Open Access
Regeneration of injured tissue: stem cell dynamics at interplay with mTORC1
Stem Cell Investigation·2018Open Access
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Cell Death and Disease·2018Open Access
The unfolded protein response impacts melanoma progression by enhancing FGF expression and can be antagonized by a chemical chaperone
Scientific Reports·2017· 35 citedOpen Access
Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation
Molecular Cancer Research·2017· 27 citedOpen Access
Rapamycin Maintains the Chondrocytic Phenotype and Interferes with Inflammatory Cytokine Induced Processes
International Journal of Molecular Sciences·2017· 25 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Wolfgang Mikulits(22), Markus Hengstschläger(18), Hartmut Beug(12), Birgit Schütz(10), Margit Rosner(8), Clemens Röhrl(7), Herbert Stangl(7), Andreas Eger(6), David Schörghofer(6), Katharina Kinslechner(6), Andrea Preitschopf(6), Roland Foisner(5), Josef Gotzmann(5), Thomas Weichhart(5), Heidemarie Huber(5), Martin Schreiber(4), Wolfgang Sommergruber(4), Norbert Schweifer(4), Rolf Schulte‐Hermann(4), Verena Proell(4)